What is the recommended amoxicillin‑clavulanate (Augmentin) dosage for a teenage girl with an Escherichia coli urinary tract infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin Dosing for Teenage Girl with E. coli UTI

For a teenage girl with an E. coli urinary tract infection, the recommended Augmentin dosage is 875 mg/125 mg twice daily for 7 days, or alternatively 500 mg/125 mg three times daily for 7 days. 1

Dosing Recommendations

Standard Dosing for Adolescents

  • Augmentin 875/125 mg tablet twice daily is the preferred formulation for teenagers who can swallow tablets 1
  • Alternative: Augmentin 500/125 mg three times daily 1
  • Duration: 7 days for uncomplicated UTI 2

Weight-Based Considerations

If the patient weighs less than 40 kg or has difficulty swallowing tablets, pediatric dosing applies:

  • 45 mg/kg/day of the amoxicillin component divided into 2 doses (using the 200 mg/28.5 mg per 5 mL or 400 mg/57 mg per 5 mL suspension) 2
  • Maximum dose should not exceed adult dosing 1

Clinical Context and Rationale

E. coli Susceptibility

E. coli remains the most common uropathogen in pediatric and adolescent UTIs, accounting for approximately 74% of positive cultures 3. However, resistance to amoxicillin-clavulanate is increasing, with recent data showing a statistically significant upward trend in resistance rates 3. Despite this:

  • Historical cure rates with amoxicillin-clavulanate for E. coli UTIs range from 85-96% 4, 5, 6, 7
  • The combination remains effective against many β-lactamase-producing strains 1, 8

Treatment Duration

Beta-lactam antibiotics for UTI should be given for 7 days based on guideline recommendations 2. This duration balances efficacy with minimizing adverse effects and resistance development.

Important Caveats

Check local antibiogram data before prescribing. If local E. coli resistance to amoxicillin-clavulanate exceeds 20%, consider alternative first-line agents such as:

  • Nitrofurantoin 100 mg twice daily for 5 days (for uncomplicated cystitis) 2
  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7 days (if local resistance <20%) 2
  • First-generation cephalosporins (cephalexin 500 mg four times daily for 7 days) 2

Administration Guidelines

  • Take at the start of meals to minimize gastrointestinal intolerance and enhance clavulanate absorption 1
  • Common side effects include gastrointestinal symptoms (9.8%) and rash (4.1%) 4
  • Candida vaginitis may develop in 14% of patients 4

When to Escalate Therapy

If symptoms suggest pyelonephritis (fever ≥38.5°C, flank pain, systemic symptoms):

  • Consider parenteral therapy initially with ceftriaxone 50-100 mg/kg/day 2
  • Can transition to oral amoxicillin-clavulanate once afebrile if susceptibility confirmed 9
  • Total treatment duration: 7-10 days 2

ESBL-Producing E. coli

If ESBL-producing E. coli is suspected or confirmed:

  • High-dose amoxicillin-clavulanate (2875 mg amoxicillin/125 mg clavulanate twice daily) may be effective in select cases 10
  • However, carbapenems remain first-line for ESBL infections 10, 11
  • Consider infectious disease consultation 9

Follow-Up

  • Routine post-treatment urine cultures are not indicated if symptoms resolve 2
  • If symptoms persist or recur within 2 weeks, obtain urine culture and susceptibility testing 2
  • Assume resistance to initial agent and use alternative therapy for 7 days 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.